| Product Information |
|
| Registration Number |
DR-XY 47704
|
| Generic Name |
Ibrutinib
|
| Brand Name |
Imbruvica
|
| Dosage Strength |
140 mg
|
| Dosage Form |
Capsule
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
White opaque HDPE bottle with white opaque child -
resistant PP closure and foil induction seal containing 90 capsules (Box of l's) White opaque HDPE bottle with white opaque child - resistant PP closure and foil induction seal containing 120 capsules (Box of l's)
|
| Pharmacologic Category |
Antineoplastic Agent (Protein Kinase Inhibitor)
|
| Manufacturer |
Cilag AG
|
| Country of Origin |
Switzerland
|
| Trader |
N/A
|
| Importer |
Johnson & Johnson (Philippines), Inc.
|
| Distributor |
N/A
|
| Application Type |
Monitored Release
|
| Issuance Date |
04 February 2022
|
| Expiry Date |
04 February 2027
|